Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10,678 GBX | -0.60% | +2.40% | +0.74% |
Mar. 28 | ASTRAZENECA : Deutsche Bank reiterates its Sell rating | ZD |
Mar. 27 | AstraZeneca CEO Sees No Impact from Biosecure Act | MT |
Evolution of the average Target Price on AstraZeneca PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AstraZeneca PLC
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
UBS | Matthew Weston |
RBC Capital Markets | |
B. Riley | |
JPMORGAN | James Gordon |
Berenberg Bank | |
BERENBERG | Luisa Hector |
JEFFERIES | Peter Welford |
DZ Bank | |
BMO Capital | |
Stifel Nicolaus | |
BARCLAYS | Emily Field |
Deutsche Bank Securities | |
alphavalue | Abhishek Raval |
Jefferies & Co. | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
Argus | |
Morgan Stanley | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Danske Bank Group | |
Kepler Capital Markets | |
Kepler Cheuvreux | |
DEUTSCHE BANK | Emmanuel Papadakis |
SVB Leerink | |
Bryan, Garnier & Co. | |
Societe Generale | |
Liberum Capital | |
ODDO BHF | |
BANK OF AMERICA (BOFA) | Sachin Jain |
EPS Revisions
- Stock
- Equities
- Stock AstraZeneca PLC - London S.E.
- Consensus AstraZeneca PLC